RSS

exclusive licence

TxCell has exercised its exclusive option to in-license the intellectual property rights of one of its academic partners, the University of British Columbia (UBC), onto its HLA-A2 CAR-Treg programme. more

Technology

Orchard Therapeutics, a clinical-stage biotechnology company, has acquired an exclusive licence to develop lentivirus-based autologous ex-vivo gene therapy for Sanfilippo syndrome type B (or MPS-IIIB) from The University of Manchester. more

News

Visterra and Vir Biotechnology have entered into a research collaboration, exclusive licence and option agreement for the development and commercialisation of select programmes for infectious diseases. more

News

The AMR Centre and Swedish company Medivir have signed an exclusive licensing agreement aimed at tackling NDM-1 and other metallo-β-lactamases, which make bacteria resistant to widely-used antibiotics. more

News

The antibody drug conjugate (ADC) development company, Glythera, has been granted exclusive, worldwide rights to Cancer Research UK’s novel CDK11 inhibitor programme for the development of multiple ADCs. more

News

Partner to the healthcare and pharma industry, Gerresheimer has announced it will complete its product portfolio of prefillable syringes through an exclusive licence from West Pharmaceutical Services. more

Technology